This inventor holds 1 USPTO granted patent. Top assignee: Centrexion Therapeutics Corporation. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Stephan George Mueller
Introduction
Stephan George Mueller is a notable inventor based in Warthausen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cannabinoid receptor agonists. His work focuses on innovative compounds that have the potential to treat various disorders.
Latest Patents
Mueller holds a patent for his invention of novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles. This invention relates to their use as CB2 cannabinoid receptor agonists, along with pharmaceutical compositions containing these compounds. The applications of his work are aimed at treating conditions mediated by the CB2 receptor.
Career Highlights
Stephan George Mueller is associated with Centrexion Therapeutics Corporation, where he continues to advance his research and development efforts. His expertise in cannabinoid receptor research has positioned him as a key figure in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Doris Riether and Florian Paul Christian Binder. Their collaborative efforts contribute to the innovative environment at Centrexion Therapeutics Corporation.
Conclusion
Stephan George Mueller's work exemplifies the intersection of innovation and pharmaceutical science. His contributions to cannabinoid receptor research are paving the way for new treatments and therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile